Been giving this sell down from Cashel Partners some more thought, particularly given the over hang of stock (circa 50m shares on offer at around .7-.8c) on offer at present. Whilst Cashel has not been a substantial shareholder since March '17 they may still have a material holding they are looking to sell. Does anyone have any knowledge of the reason for their sale? My own view is that ABV has turned the corner and is firmly on the road to commercial success with its expanded range of products/markets, outsourcing and cost control. So I struggle to believe that the reason is entirely based on a view as to whether the company will succeed, rather it could well be that their holding is held within their Fund #1. As that fund is a closed end, unlisted, terminating structure that must be unwound by a certain date they may've been forced to liquidate their holding as they simply ran out of time. I do not know if this the case, it is merely one possible explanation for their sell down. Does anyone have any information on Cashel's real reason for selling?
- Forums
- ASX - By Stock
- Ann: Ceasing to be and Becoming a substantial holder
Been giving this sell down from Cashel Partners some more...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ABV (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.8¢ |
Change
-0.001(1.12%) |
Mkt cap ! $28.70M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 8.8¢ | $21.89K | 244.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8791 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 131787 | 0.012 |
1 | 100000 | 0.010 |
1 | 700561 | 0.009 |
2 | 10000000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 371498 | 2 |
0.015 | 528000 | 2 |
0.016 | 119374 | 2 |
0.017 | 687500 | 3 |
0.019 | 575000 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
ABV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online